Close Menu
Home » Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Precision Cancer Software Startup BostonGene Lands $50M in Series A Round

Apr 25, 2019
|
staff reporter

NEW YORK (GenomeWeb) – Biomedical software startup BostonGene today announced that it has received a $50 million Series A investment from Japanese software giant NEC.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

From the Depths

Researchers have sequenced the genome of the depth-dwelling giant squid.

Not the Research Topic

Prosecutors have charged a former Drexel University professor with theft for allegedly spending federal grant money on adult entertainment and other unrelated expenses, according to the Philadelphia Inquirer.

 

Prison in Insider Trading Case

Chris Collins, a former US representative, has been sentenced to more than two years in prison in an insider trading case involving an Australian biotechnology firm, the New York Times reports.

PNAS Papers on Trypanosoma brucei Transcripts, Inherited Retinal Disease, Gut Microbiome Development

In PNAS this week: Trypanosoma brucei transcripts, estimate of people at risk of inherited retinal disease, and more.

What's Popular?

In Business News

  1. Illumina Targets Single-Cell, Oncology Applications With New NextSeq Platform

    Premium

  2. JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

  3. Novigenix-led Collaboration Receives €1M European Funding for Colorectal Cancer Multi-Omics Research

  4. JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

  5. Revocation of Broad Institute CRISPR Patent Upheld in Europe

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.